Helping to maintain the integrity of your brand by safeguarding patents and intellectual property internationally

The Pharma and Biotech industry have a diverse and specific need for the range of services that Watchwood can offer. We have an extensive proven track record with the biggest names in the industry for providing fast and effective answers that can be relied on.
In particular the industry has a very critical need for detailed, robust and accurate intelligence that it can rely on from the international courtroom to the boardroom.

Pharma and Biotech companies are involved in a raft of international operations from distribution to manufacturing and therefore need to be able to make informed decisions with regards to International Compliance, Corporate Social Responsibility and Business Ethics.

The pharmaceutical and biotech industry is also vulnerable to IP theft, and drug counterfeiting has become a multi-billion dollar global industry. Safeguarding patents and intellectual property is a continually evolving challenge. To maintain the integrity of your brand, it is vital that you have in place strategies to minimise risk and respond decisively to IP infringements.

At Watchwood we have the resources to pursue counterfeiting and IP theft wherever they may exist. This includes jurisdictions where anti-counterfeiting laws are weak and legal sanctions difficult to enforce.  We work to identify, assess and prevent illegal operations, gathering actionable intelligence relating to counterfeiting or parallel trading. We support litigation, liaising with international law enforcement agencies and customs authorities to hold offenders to account.  Vitally, we also assist with developing cost-effective strategies to identify vulnerable areas and mitigate future risk.

Need expert security advice you can trust?

We will be pleased to arrange a confidential consultation anywhere in the world.

Contact Us

Latest News

Hack Will Lead to Little, if Any, Punishment for Equifax

The hacking into Equifax’s trove of consumer and financial data that exposed the sensitive personal information of as many as 143 million Americans leads naturally to the question of the legal consequences the company and its executives might face. The answer, for those who remember the government’s response to the financial crisis, will be as … Continued

Read article

Cyber-security: More than 1,000 attacks reported in UK

The centre – part of the intelligence agency GCHQ – says more than half the incidents posed a significant threat. None of the incidents was category one level involving interference with the democratic system or crippling critical infrastructure such as power. But NCSC head Ciaran Martin warned there could be more significant and damaging attacks … Continued

Read article